British Journal of Medical & Surgical Urology
Volume 2, Issue 3 , Pages 127-128 , May 2009

Paraplegia as a complication of intravesical Botulinum toxin A (Dysport®) injection for overactive bladder

Received 14 September 2008 ,Revised 17 November 2008 ,Accepted 23 November 2008.

References 

  1. Dolly O. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. Headache. 2003;43(Suppl 1):S16–S24
  2. Grosse J, Kramer G, Stohrer M. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol. 2005;47:653–659
  3. De Laet K, Wyndaele JJ. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord. 2005;43:397–399
  4. Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int. 2007;100:1302–1306
  5. Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P. What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity?. BJU Int. 2006;97:1030–1034
  6. Wiegand H, Erdmann G, Wellhoner HH. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol. 1976;292:161–165

PII: S1875-9742(08)00130-4

doi: 10.1016/j.bjmsu.2008.11.012

British Journal of Medical & Surgical Urology
Volume 2, Issue 3 , Pages 127-128 , May 2009

Article Tools